Viewing Study NCT00858403


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2026-04-18 @ 4:04 AM
Study NCT ID: NCT00858403
Status: TERMINATED
Last Update Posted: 2014-01-15
First Post: 2009-03-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MCC-15656
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View